Bastien Joubert Selected Research

Bastien Joubert Research Topics

Disease

15	Encephalitis (Encephalitis, Rasmussen) 04/2024 - 10/2015
15	Neoplasms (Cancer) 03/2024 - 10/2015
13	Autoimmune Diseases of the Nervous System 05/2024 - 10/2015
13	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2024 - 01/2016
10	Cerebellar Ataxia (Dysmetria) 03/2024 - 04/2016
8	Glioma (Gliomas) 05/2024 - 11/2017
8	Ataxia (Dyssynergia) 02/2023 - 04/2016
5	Nervous System Diseases (Neurological Disorders) 01/2023 - 01/2020
4	Seizures (Absence Seizure) 01/2023 - 01/2016
4	Isaacs Syndrome (Neuromyotonia) 10/2022 - 01/2016
4	Epilepsy (Aura) 09/2022 - 01/2019
4	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2018
3	Central Nervous System Diseases (CNS Diseases) 04/2024 - 01/2022
3	Nervous System Paraneoplastic Syndromes 01/2023 - 11/2019
3	Myasthenia Gravis 03/2022 - 03/2017
3	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2021 - 01/2018
3	Thymoma (Thymic Carcinoma) 10/2020 - 01/2016
2	Leukocytosis (Pleocytosis) 05/2024 - 10/2021
2	Cognitive Dysfunction 05/2024 - 05/2018
2	Brain Diseases (Brain Disorder) 03/2024 - 01/2018
2	Melanoma (Melanoma, Malignant) 03/2024 - 01/2020
2	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 03/2024 - 01/2024
2	Myositis (Idiopathic Inflammatory Myopathies) 03/2024 - 01/2018
2	Mesothelioma 01/2024 - 11/2019
2	Paraneoplastic Cerebellar Degeneration 02/2023 - 04/2016
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2023 - 01/2022
2	Autoimmune limbic encephalitis 01/2023 - 10/2022
2	Inflammation (Inflammations) 01/2022 - 08/2021
2	Anterograde Amnesia 01/2022 - 01/2017
2	Disease Progression 01/2022 - 05/2018
2	Genetic Predisposition to Disease (Genetic Predisposition) 07/2021 - 07/2020
2	Temporal Lobe Epilepsy 07/2021 - 07/2020
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 03/2017
1	Neuromyelitis Optica (Devic's Disease) 04/2024
1	Meningoencephalitis 03/2024
1	Polyradiculoneuropathy (Polyradiculoneuritis) 03/2024
1	Multiple Sclerosis 01/2024
1	Vasculitis (Vasculitides) 01/2024
1	Malignant Mesothelioma 01/2024
1	Mononeuropathies (Mononeuritis Multiplex) 01/2024
1	Carcinoma (Carcinomatosis) 02/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023
1	Encephalomyelitis (Myeloencephalitis) 01/2023
1	Movement Disorders (Movement Disorder) 01/2023
1	Myoclonus (Nocturnal Myoclonus) 01/2023
1	Pain (Aches) 01/2023
1	Sleep Wake Disorders 01/2023
1	Tremor (Tremors) 01/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023
1	Neuromuscular Diseases (Neuromuscular Disease) 10/2022
1	Drug Resistant Epilepsy 09/2022
1	Meningitis 03/2022
1	Lung Neoplasms (Lung Cancer) 03/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Memory Disorders (Memory Loss) 01/2022
1	Neurosarcoidosis 01/2022
1	Sarcoidosis (Schaumann Disease) 01/2022

Drug/Important Bio-Agent (IBA)

34	AntibodiesIBA 05/2024 - 10/2015
14	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2015
13	AutoantibodiesIBA 05/2023 - 10/2015
10	Immune Checkpoint InhibitorsIBA 03/2024 - 11/2019
7	Leucine (L-Leucine)FDA Link 05/2024 - 10/2020
5	AntigensIBA 02/2023 - 01/2019
5	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 07/2021 - 10/2019
4	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024 - 01/2022
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	IpilimumabIBA 01/2024 - 11/2019
3	NivolumabIBA 01/2024 - 01/2018
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023 - 05/2018
2	N-Methylaspartate (NMDA)IBA 05/2023 - 05/2018
2	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 01/2023 - 09/2022
2	Surface Antigens (Surface Antigen)IBA 08/2022 - 03/2017
2	adenylate kinase 5IBA 10/2021 - 01/2017
2	Netrin-1IBA 10/2020 - 03/2017
2	SteroidsIBA 01/2020 - 01/2020
2	Lomustine (CCNU)FDA Link 05/2018 - 11/2017
2	Bevacizumab (Avastin)FDA Link 05/2018 - 11/2017
2	Temozolomide (Temodar)FDA LinkGeneric 05/2018 - 11/2017
2	Glutens (Glutelin)IBA 01/2018 - 04/2016
1	gamma-Aminobutyric Acid (GABA)IBA 05/2024
1	Myelin-Oligodendrocyte GlycoproteinIBA 04/2024
1	Melanoma-Specific AntigensIBA 03/2024
1	Immunoglobulin A (IgA)IBA 01/2024
1	anti-Yo autoantibodiesIBA 02/2023
1	anti-CASPR2 autoantibodyIBA 01/2023
1	mesoglycanIBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 03/2022
1	LigandsIBA 03/2022
1	EpitopesIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	ElementsIBA 01/2022
1	AD 20 (AD-20)IBA 01/2022

Therapy/Procedure

7	Immunotherapy 05/2024 - 01/2017
6	Therapeutics 01/2024 - 01/2016
2	Precision Medicine 01/2022 - 01/2019
2	Drug Therapy (Chemotherapy) 05/2018 - 11/2017